IBO — Universal Ibogaine Balance Sheet
0.000.00%
- CA$7.72m
- CA$10.04m
- CA$2.33m
Annual balance sheet for Universal Ibogaine, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | 2024 July 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.726 | 0.313 | 0.371 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.231 | 0.076 | 0.194 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 1.02 | 0.443 | 1.04 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 5.3 | 3.66 | 3.47 |
Other Long Term Assets | |||
Total Assets | 6.32 | 5.5 | 4.51 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 2.19 | 2.79 | 0.998 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 2.37 | 3.75 | 3.52 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 3.94 | 1.75 | 0.991 |
Total Liabilities & Shareholders' Equity | 6.32 | 5.5 | 4.51 |
Total Common Shares Outstanding |